BCRX Financial Overview

Comprehensive financial analysis and stock performance data for BCRX. This dashboard provides key metrics, financial ratios, and interactive charts to help you make informed investment decisions.

BCRX

BioCryst Pharmaceuticals, Inc.

Healthcare
CEO: Jon P. Stonehouse
IPO: 1994-03-04
580 employees
$8.53
0.18 (2.11%)

Market Cap

1.79B

Enterprise Value

2B

Revenue (TTM)

450.7M

Net Income

-88,881,000

P/E Ratio

-49.97x

ROE

7.86%

Valuation Metrics
Market Cap
2B
Enterprise Value
2B
P/E Ratio
-49.97x
P/S Ratio
3.21x
P/B Ratio
-4.23x
EV/Sales
4.38x
EV/FCF
-89.46x
Earnings Yield
-2.00%
FCF Yield
-1.52%
Price to Operating Cash Flow
-67.97x
Gross Margin
97.00%
Margin Metrics
Operating Margin
9.72%
Net Margin
-6.41%
Pretax Margin
-5.77%
ROIC
18.92%
Dividends
Payout Ratio
0.00%
Dividend Yield
0.00%
Dividend per Share
$0.00
Return Metrics
ROE
7.86%
ROCE
19.35%
ROA
-7.81%
PEG Ratio
-1.62x
Payout Ratio
0.00%
Financial Health
Debt to Assets
161.62%
Net Debt/EBITDA
-23.76x
Growth Metrics
3Y Revenue Growth
35.45%
5Y Revenue Growth
38.85%
10Y Revenue Growth
26.75%
3Y Net Income Growth
16.51%
5Y Net Income Growth
9.66%
10Y Net Income Growth
3.16%
3Y OCF Growth
18.95%
5Y OCF Growth
10.87%
10Y OCF Growth
4.57%

Stock Performance

Interactive stock chart with historical price data and comparison tools. Analyze price movements, volume trends, and compare with other stocks or indices.

Error loading chart data. Please try refreshing the page.
BioCryst Pharmaceuticals, Inc. | Financial Overview | Monexa